Bolt Biotherapeutics CEO William P. Quinn acquires 637 common shares valued at $2,469.01 - BOLT News | RalliesBolt Biotherapeutics CEO William P. Quinn acquires 637 common shares valued at $2,469.01
B
BOLT• Quinn’s reported share transactions
- Bolt Biotherapeutics President, CEO, CFO, and director William P. Quinn cut his common-stock stake to 25,384 shares.
- Sold 17,566 shares in multiple transactions at weighted average prices of $3.77, $3.32, and $3.24.
- Also bought 637 shares at $3.88, lifting his holdings to 2,950 shares before the later sales.
TOP
•
